See more : Scottish Mortgage Investment Trust PLC (SMT.L) Income Statement Analysis – Financial Results
Complete financial analysis of C-Bond Systems, Inc. (CBNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of C-Bond Systems, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Vascon Engineers Limited (VASCONEQ.BO) Income Statement Analysis – Financial Results
- GACM Technologies Limited (GATECH.NS) Income Statement Analysis – Financial Results
- Omnichannel Acquisition Corp. (OCA-UN) Income Statement Analysis – Financial Results
- TuHURA Biosciences, Inc. (HURA) Income Statement Analysis – Financial Results
- Orefinders Resources Inc. (ORX.V) Income Statement Analysis – Financial Results
C-Bond Systems, Inc. (CBNT)
About C-Bond Systems, Inc.
C-Bond Systems, Inc., a nanotechnology company, owns, develops, manufactures, and sells patented C-Bond technology in the United Sates. The company's products include C-Bond NanoShield, a patented nanotechnology windshield glass strengthening and hydrophobic all-in-one performance system to improve windshield safety and performance; C-Bond Secure, a patented non-toxic water-based nanotechnology solution to improve the strength of architectural glass and performance properties of window film-to-glass products; and C-Bond BRS, a patented nanotechnology ballistic-resistant film system that increases the structural integrity of glass. It also distributes MB-10 and Vimoba disinfectant tablets to school facilities and buses, dealerships, global distribution network, and service providers, as well as the transportation detailing, automotive, trucking, RV, rental agency, service vehicles, mass transit, golf carts, aviation, train, and marine markets. The company was founded in 2013 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.49M | 2.23M | 1.48M | 658.43K | 602.64K | 382.24K | 405.42K | 723.61K | 0.00 | 0.00 | 77.70K | 85.12K | 105.00K | 124.77K | 124.64K | 77.84K |
| Cost of Revenue | 1.18M | 954.40K | 657.30K | 242.51K | 121.97K | 83.38K | 7.96M | 2.28K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.31M | 1.28M | 819.53K | 415.93K | 480.67K | 298.86K | -7.56M | 721.33K | -4.65K | 0.00 | 77.70K | 85.12K | 105.00K | 124.77K | 124.64K | 77.84K |
| Gross Profit Ratio | 52.54% | 57.25% | 55.49% | 63.17% | 79.76% | 78.19% | -1,863.73% | 99.68% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | -3.25K | 16.63K | 31.06K | 258.29K | 214.11K | 220.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.27M | 4.47M | 7.83M | 4.88M | 6.81M | 9.31M | 559.98K | 636.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 31.74K | 69.74K | 65.63K | 46.28K | 36.24K | 51.72K | -502.83K | -583.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.24M | 4.47M | 7.83M | 4.88M | 6.81M | 9.31M | 57.14K | 53.00K | 63.50K | 52.49K | 71.97K | 58.68K | 57.45K | 58.77K | 113.46K | 127.44K |
| Other Expenses | 0.00 | 1.89M | 5.50M | 6.57K | 5.12M | -200.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -747.89K | 4.47M | 7.83M | 4.89M | 6.84M | 9.57M | 57.14K | 53.00K | 63.50K | 52.49K | 71.97K | 58.68K | 57.45K | 58.77K | 113.46K | 127.44K |
| Cost & Expenses | 433.09K | 5.43M | 8.49M | 5.14M | 6.96M | 9.65M | 57.14K | 53.00K | 63.50K | 52.49K | 71.97K | 58.68K | 57.45K | 58.77K | 113.46K | 127.44K |
| Interest Income | 0.00 | 1.62M | 282.96K | 751.18K | 343.08K | 0.00 | 125.00 | 140.00 | 123.00 | 129.00 | 173.00 | 216.00 | 431.00 | 936.00 | 3.38K | 8.47K |
| Interest Expense | 475.43K | 1.62M | 282.96K | 751.18K | 343.08K | 53.14K | 125.00 | 140.00 | 123.00 | 129.00 | 173.00 | 216.00 | 431.00 | 936.00 | 3.38K | 8.47K |
| Depreciation & Amortization | 88.86K | 90.30K | 45.60K | 14.49K | 24.63K | 33.72K | 38.30K | 2.28K | 4.65K | 4.65K | 2.37K | 0.00 | 3.58K | 3.27K | 2.90K | 2.85K |
| EBITDA | 2.45M | -3.45M | -6.80M | -3.67M | -6.87M | -9.82M | -8.25M | -50.58K | -58.72K | -47.71K | 8.10K | 26.66K | 51.13K | 69.27K | 14.08K | -38.28K |
| EBITDA Ratio | 98.50% | -139.00% | -471.56% | -677.81% | -1,051.05% | -2,415.83% | -14.09% | -7.01% | 0.00% | 0.00% | 10.43% | 31.06% | 48.69% | 55.52% | 11.29% | -60.07% |
| Operating Income | 2.06M | -3.19M | -7.01M | -4.48M | -6.36M | -9.27M | -57.14K | -53.00K | -63.50K | -52.49K | 5.73K | 26.44K | 47.55K | 66.00K | 11.18K | -49.61K |
| Operating Income Ratio | 82.60% | -142.99% | -474.67% | -679.95% | -1,055.13% | -2,424.66% | -14.09% | -7.32% | 0.00% | 0.00% | 7.37% | 31.06% | 45.28% | 52.90% | 8.97% | -63.73% |
| Total Other Income/Expenses | -168.60K | -1.96M | -118.74K | 42.59K | -882.13K | -636.62K | -8.01K | 140.00 | 123.00 | 129.00 | 173.00 | 216.00 | 431.00 | 936.00 | 3.38K | 8.47K |
| Income Before Tax | 1.89M | -5.16M | -7.13M | -4.43M | -7.24M | -9.90M | -57.02K | -52.86K | -63.38K | -52.36K | 5.90K | 26.66K | 47.98K | 66.94K | 14.55K | -41.13K |
| Income Before Tax Ratio | 75.82% | -230.96% | -482.71% | -673.49% | -1,201.51% | -2,591.20% | -14.06% | -7.30% | 0.00% | 0.00% | 7.59% | 31.31% | 45.69% | 53.65% | 11.68% | -52.84% |
| Income Tax Expense | 0.00 | 305.38K | 298.48K | 751.18K | 343.08K | 583.48K | -250.00 | -280.00 | -246.00 | 457.00 | -152.00 | 5.04K | 9.09K | 2.08K | -6.75K | -16.95K |
| Net Income | 1.90M | -5.46M | -7.43M | -5.19M | -7.58M | -9.90M | -57.02K | -52.86K | -63.38K | -52.82K | 6.05K | 21.61K | 38.89K | 64.86K | 14.55K | -41.13K |
| Net Income Ratio | 76.18% | -244.64% | -502.93% | -787.57% | -1,258.44% | -2,591.20% | -14.06% | -7.30% | 0.00% | 0.00% | 7.79% | 25.39% | 37.04% | 51.98% | 11.68% | -52.84% |
| EPS | 0.00 | -0.02 | -0.03 | -0.03 | -0.08 | -0.14 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | -0.03 | -0.03 | -0.08 | -0.14 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 490.11M | 308.12M | 254.30M | 172.98M | 94.24M | 68.52M | 45.28M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M |
| Weighted Avg Shares Out (Dil) | 2.52B | 308.12M | 254.30M | 172.98M | 94.24M | 68.52M | 45.28M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M |
C-Bond Systems Acquires A1 Glass Coating of San Antonio, Texas, and Expects to Add $2 Million of Annual Revenue
A1 Glass Is a Premier Distributor and Expert Installer of C-Bond Products
C-Bond Systems' Distributor A1 Glass Coating Expands Pipeline for C-Bond BRS Projects to Four More Texas Schools and Expects to Recognize an Additional $300,000 in Revenue from these Pending Jobs
These four new pipeline projects are in addition to the 12 schools and $200,000 of expected revenue for A1 Glass Coating that C-Bond announced in April 2021, bringing the total amount of expected revenue for A1 Glass to over $500,000...
C-Bond Systems Receives $50,000 Purchase Order to Supply its Ballistic-Resistant System, C-Bond BRS, to Texas School District
C-Bond BRS has been independently validated to provide NIJ Level I, Level II, Level IIA, and UL 752 ballistic-resistant protection C-Bond BRS has been independently validated to provide NIJ Level I, Level II, Level IIA, and UL 752 ballistic-resistant protection
C-Bond Systems Files U.S. Provisional Patent for “Self-Healing Glass” for the Automotive Sector
Development for the invention is being led by world renowned chemist Professor Andrew R. Barron who has been granted over 50 patents Development for the invention is being led by world renowned chemist Professor Andrew R. Barron who has been...
C-Bond Systems' Premier Distributor, A1 Glass Coating, Increases its Pipeline for C-Bond BRS Projects to 12 Schools in 6 Different Texas School Districts and Expects to Recognize More Than $200,000 in Revenue from these Pending Jobs
HOUSTON, April 29, 2021 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that its premier distributor, A1 Glass Coating, has increased its pipeline for C-Bond BRS (ballistic-resistant system) projects to 12...
Nanotechnology: Reshaping Our Lives, Creating New Opportunities
The nanotechnology space is worth keeping an eye on.
CBond Systems, Inc. (CBNT) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
CBond Systems, Inc. (CBNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
C-Bond Systems Promotes Allison Tomek to President and Member of its Board of Directors
Tomek joined the Company in 2018 as Vice President of Corporate Communications and Corporate Secretary Tomek joined the Company in 2018 as Vice President of Corporate Communications and Corporate Secretary
C-Bond nanoShield Chosen by Major Metropolitan U.S. City to Protect its Fleet of Municipal Vehicles from Windshield Chips and Cracks
C-Bond products can help state and federal government agencies such as the U.S. Postal Service, military, and more to protect their fleets to decrease windshield repair and replacement costs and reduce vehicle downtime
C-Bond Systems Retains World-Renowned Chemist and Nanotechnology Expert Professor Andrew R. Barron to Initiate a Strategic Technology Development Project: “Self-Healing Glass” for the Automotive Sector
C-Bond CEO Scott R. Silverman and Professor Barron Will Hold a Conference Call Today at 10:30 am EST to Discuss this Technology Development Initiative and Milestones C-Bond CEO Scott R. Silverman and Professor Barron Will Hold a Conference Call Today...
Source: https://incomestatements.info
Category: Stock Reports